Patient with hypofibrinolysis-mediated thromboembolism converted to a hypercoagulable/hyperfibrinolytic state via ventricular assist device placement.
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D017548:Echocardiography, Transesophageal; D005260:Female; D005342:Fibrinolysis / Q000502:physiology*; D006352:Heart Ventricles / Q000503:physiopathology*; D006353:Heart-Assist Devices / Q000706:statistics & numerical data*; D006487:Hemostasis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D013923:Thromboembolism / Q000000981:diagnostic imaging / Q000209:etiology* / Q000601:surgery*; D019851:Thrombophilia / Q000503:physiopathology*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin; D001241:Aspirin